Dolutegravir/emtricitabine/tenofovir alafenamide - Lupin Pharmaceuticals
Alternative Names: DTG/FTC/TDF - Lupin PharmaceuticalLatest Information Update: 28 Feb 2023
At a glance
- Originator Lupin Pharmaceuticals
- Class 3-ring heterocyclic compounds; Amides; Antiretrovirals; Deoxyribonucleosides; Dideoxynucleosides; Phosphonic acids; Purines; Pyrimidine nucleosides
- Mechanism of Action HIV integrase inhibitors; Nucleoside reverse transcriptase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Registered HIV-1 infections